(Q51474535)

English

Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trial.

scientific article published in May 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17391168

Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17391168

type 2 diabetes

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17391168

Casper G. Schalkwijk

4

object named as

Schalkwijk CG

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17391168

author name string

Lund SS

1

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17391168

Stehouwer CD

3

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17391168

Frandsen M

5

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17391168

Smidt UM

6

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17391168

Pedersen O

7

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17391168

Parving HH

8

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17391168

Vaag A

9

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17391168

publication date

1 May 2007

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17391168

Diabetes, Obesity and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17391168

9

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17391168

3

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17391168

394-407

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17391168

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00713.X

21 January 2018

Oral antihyperglycemic therapy for type 2 diabetes: scientific review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00713.X

21 January 2018

Waist circumference, waist-hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00713.X

21 January 2018

A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00713.X

21 January 2018

Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00713.X

21 January 2018

Comparison of glycaemic control and cardiovascular risk profile in patients with type 2 diabetes during treatment with either repaglinide or metformin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00713.X

21 January 2018

Genetic cause of hyperglycaemia and response to treatment in diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00713.X

21 January 2018

The effect of obesity on glycaemic response to metformin or sulphonylureas in Type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00713.X

21 January 2018

Pharmacology and clinical experience with repaglinide

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00713.X

21 January 2018

Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00713.X

21 January 2018

Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00713.X

21 January 2018

Repaglinide in type 2 diabetes: a 24-week, fixed-dose efficacy and safety study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00713.X

21 January 2018

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00713.X

21 January 2018

Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00713.X

21 January 2018

Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00713.X

21 January 2018

Statistical methods for assessing agreement between two methods of clinical measurement

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00713.X

21 January 2018

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00713.X

21 January 2018

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00713.X

21 January 2018

Repaglinide versus glyburide: a one-year comparison trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00713.X

21 January 2018

Comparison between repaglinide and glipizide in Type 2 diabetes mellitus: a 1-year multicentre study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00713.X

21 January 2018

Metformin: new understandings, new uses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00713.X

21 January 2018

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00713.X

21 January 2018

Body-Mass Index and Mortality in a Prospective Cohort of U.S. Adults

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00713.X

21 January 2018

Guidelines for healthy weight

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00713.X

21 January 2018

Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00713.X

21 January 2018

Metformin monotherapy for type 2 diabetes mellitus

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD002966.PUB3

Identifiers

10.1111/J.1463-1326.2007.00713.X

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17391168

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17391168

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51474535&oldid=2040536266"